P Weidmann
Nephropathy subsequent to hyperlipidemia
Teuscher A, Weidmann P, Lerch M, Laissue J. Nephropathy subsequent to hyperlipidemia. Clinical nephrology 2000; 54:64-7.
Jul 1, 2000Nephropathy subsequent to hyperlipidemia
Jul 1, 2000Clinical nephrology 2000; 54:64-7
Teuscher A U, Weidmann P, Lerch Marianne, Laissue J A
Metabolic effects of temocapril in hypertensive patients with diabetes mellitus type 2
Lerch M, Weidmann P, Ho M, Gerber P, Eckenberger P, Kaemmereit A, Teuscher A. Metabolic effects of temocapril in hypertensive patients with diabetes mellitus type 2. Journal of cardiovascular pharmacology 1999; 33:527-33.
Apr 1, 1999Metabolic effects of temocapril in hypertensive patients with diabetes mellitus type 2
Apr 1, 1999Journal of cardiovascular pharmacology 1999; 33:527-33
Lerch Marianne, Weidmann P, Ho M P, Gerber P, Eckenberger P, Kaemmereit A, Teuscher A U
Endothelin-1 infusion inhibits plasma insulin responsiveness in normal men
Teuscher A, Lerch M, Shaw S, Pacini G, Ferrari P, Weidmann P. Endothelin-1 infusion inhibits plasma insulin responsiveness in normal men. Journal of hypertension 1998; 16:1279-84.
Sep 1, 1998Endothelin-1 infusion inhibits plasma insulin responsiveness in normal men
Sep 1, 1998Journal of hypertension 1998; 16:1279-84
Teuscher A U, Lerch Marianne, Shaw S, Pacini G, Ferrari P, Weidmann P
Effects of angiotensin II-receptor blockade with losartan on insulin sensitivity, lipid profile, and endothelin in normotensive offspring of hypertensive parents
Lerch M, Teuscher A, Beissner P, Schneider M, Shaw S, Weidmann P. Effects of angiotensin II-receptor blockade with losartan on insulin sensitivity, lipid profile, and endothelin in normotensive offspring of hypertensive parents. Journal of cardiovascular pharmacology 1998; 31:576-80.
Apr 1, 1998Effects of angiotensin II-receptor blockade with losartan on insulin sensitivity, lipid profile, and endothelin in normotensive offspring of hypertensive parents
Apr 1, 1998Journal of cardiovascular pharmacology 1998; 31:576-80
Lerch Marianne, Teuscher A U, Beissner P, Schneider M, Shaw S G, Weidmann P
Metabolic neutrality of combined verapamil-trandolapril treatment in contrast to beta-blocker-low-dose chlortalidone treatment in hypertensive type 2 diabetes
Schneider M, Lerch M, Papiri M, Buechel P, Boehlen L, Shaw S, Risen W, Weidmann P. Metabolic neutrality of combined verapamil-trandolapril treatment in contrast to beta-blocker-low-dose chlortalidone treatment in hypertensive type 2 diabetes. Journal of hypertension 1996; 14:669-77.
May 1, 1996Metabolic neutrality of combined verapamil-trandolapril treatment in contrast to beta-blocker-low-dose chlortalidone treatment in hypertensive type 2 diabetes
May 1, 1996Journal of hypertension 1996; 14:669-77
Schneider M, Lerch Marianne, Papiri M, Buechel P, Boehlen L, Shaw S, Risen W, Weidmann P
Reduced plasma cyclic GMP but normal renal responses to atrial natriuretic factor in pre-hypertension
Ferrari P, Gadient G, Cozzio A, Shaw S, Weidmann P. Reduced plasma cyclic GMP but normal renal responses to atrial natriuretic factor in pre-hypertension. Blood Press 1996; 5:16-26.
Jan 1, 1996Reduced plasma cyclic GMP but normal renal responses to atrial natriuretic factor in pre-hypertension
Jan 1, 1996Blood Press 1996; 5:16-26
Ferrari P, Gadient G, Cozzio Antonio, Shaw S, Weidmann P